OC&C advises Vitabiotics on its sale to Bain Capital

We are delighted to congratulate Vitabiotics on its agreement to be acquired by Bain Capital. OC&C provided sell-side commercial support to Vitabiotics.

Founded in 1971, Vitabiotics has grown into the UK’s leading vitamins, minerals and supplements business, with a portfolio of trusted, science-led brands including Pregnacare, Wellwoman, Wellman, Perfectil, Osteocare and the Ultra range. Today, the business reaches consumers in more than 70 countries through its strong international platform, underpinned by a longstanding commitment to scientific research, innovation and quality.

Bain Capital’s acquisition marks an exciting new chapter for the business. Leveraging its global healthcare and consumer investment expertise, Bain Capital plans to support Vitabiotics’ continued international expansion, investing in digital capabilities, e-commerce, international distribution, supply chain resilience and product innovation. The UK will remain central to the company’s operations as it continues to build on its market-leading position and accelerate growth across key international markets.

OC&C, Consumer Goods, and Private Equity

OC&C is a leading global strategy consultancy with deep expertise across Wellness, Consumer Health and Consumer Goods. We advise category leaders, challenger brands and investors on the trends shaping the industry.

In private equity, we have commercially advised on more than 500 successful transactions over the past five years, supporting investors and management teams across buy-side and sell-side commercial due diligence, value creation, and growth strategy. Our combination of deep sector expertise and commercial insight helps clients navigate an increasingly dynamic wellness market and unlock long-term value.

How we help:

• Commercial due diligence and vendor due diligence for transactions.
• Strategic support to maximise value through the sale process.
• Growth strategy and international expansion planning.
• Value creation programmes to accelerate portfolio company performance.
• Identification and assessment of attractive investment opportunities and themes.

To find out more about our Wellness and Private Equity expertise, please get in touch with our team or email [email protected].